Literature DB >> 8842128

Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in west Africa.

V Robert1, J F Molez, J F Trape.   

Abstract

Patients with Plasmodium falciparum infections were selected with an in vivo chloroquine sensitivity assay. Fourteen days after treatment, the gametocytes were studied in relation to asexual parasite responses classified as drug-sensitive or showing RI or RII resistance. Gametocyte prevalence and density appeared significantly higher in RII than RI strains and higher in RI than in sensitive strains. This finding on gametocyte variation in vivo may explain why the RII type of chloroquine resistance has became more prevalent than RI everywhere in tropical Africa in the short time since its emergence. The biological and epidemiologic advantage of chloroquine-resistant malaria mediated through gametocytes is discussed in the context of the present drug pressure in Africa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842128     DOI: 10.4269/ajtmh.1996.55.350

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.

Authors:  Rashad Abdul-Ghani; Hoda F Farag; Amal F Allam; Ahmed A Azazy
Journal:  Parasitol Res       Date:  2014-02-22       Impact factor: 2.289

2.  Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

Authors:  E Tjitra; S Suprianto; J McBroom; B J Currie; N M Anstey
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.

Authors:  Florian Marks; Jennifer Evans; Christian G Meyer; Edmund N Browne; Christa Flessner; Vera von Kalckreuth; Teunis A Eggelte; Rolf D Horstmann; Jürgen May
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 4.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Disruption of a Plasmodium falciparum gene linked to male sexual development causes early arrest in gametocytogenesis.

Authors:  Tetsuya Furuya; Jianbing Mu; Karen Hayton; Anna Liu; Junhui Duan; Louis Nkrumah; Deirdre A Joy; David A Fidock; Hisashi Fujioka; Akhil B Vaidya; Thomas E Wellems; Xin-zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

Review 6.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

7.  Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum.

Authors:  Jennifer M Peters; Nanhua Chen; Michelle Gatton; Michael Korsinczky; Elizabeth V Fowler; Sergio Manzetti; Allan Saul; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Risk factors for Plasmodium falciparum gametocyte positivity in a longitudinal cohort.

Authors:  Laura Grange; Cheikh Loucoubar; Olivier Telle; Adama Tall; Joseph Faye; Cheikh Sokhna; Jean-François Trape; Anavaj Sakuntabhai; Jean-François Bureau; Richard Paul
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

9.  A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.

Authors:  Badria El-Sayed; Salah-Eldin El-Zaki; Hamza Babiker; Nahla Gadalla; Tellal Ageep; Fathi Mansour; Omer Baraka; Paul Milligan; Ahmed Babiker
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

10.  Epidemiological models for the spread of anti-malarial resistance.

Authors:  J C Koella; R Antia
Journal:  Malar J       Date:  2003-02-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.